Study on the effect of oral isotretinoin on skin photosensitivity in patients with moderate to severe acne

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300071040

Enrollment

Unknown

Registered

2023-04-30

Start date

2023-05-01

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne

Interventions

Test group: isotretinoin (10mg-20mg/d)

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Voluntary participation in this trial, signed informed consent form, agreed to the treatment protocol and completed follow-up tests; age between 18 and 45 years, male and female; met diagnostic criteria for moderate to severe acne; skin Fitzpatrick type III-IV; no previous oral isotretinoin treatment.

Exclusion criteria

Exclusion criteria: Failure to complete informed consent; clear history of allergy to isotretinoin (retinoids); recent (within = 3 months) drug or physical therapy for any skin disease or systemic disease; pregnant or lactating women; those who are preparing for pregnancy and have a pregnancy plan.

Design outcomes

Primary

Measure	Time frame
MED;MPPD;ITA;	—

Countries

China

Contacts

Public ContactWei Hua

West China Hospital, Sichuan University

huawei1007@qq.com+86 18123377561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026